Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 12.1 (12.1, 12.2) N/A 45,360 63.4
California 3 *** 12.0 (11.8, 12.1) 34 (26, 35) 5,043 65.7
Florida 6 *** 11.2 (11.0, 11.3) 36 (34, 40) 3,098 47.5
New York 3 *** 13.1 (12.9, 13.3) 13 (7, 21) 3,063 61.0
Texas 6 *** 10.1 (9.9, 10.3) 43 (41, 45) 2,747 58.3
Pennsylvania 6 *** 14.0 (13.8, 14.3) 5 (3, 9) 2,314 67.3
Illinois 6 *** 12.9 (12.7, 13.2) 18 (9, 25) 1,896 66.5
Ohio 6 *** 13.0 (12.8, 13.3) 15 (8, 24) 1,855 67.9
Michigan 5 *** 13.0 (12.7, 13.3) 14 (8, 25) 1,587 66.5
North Carolina 6 *** 12.0 (11.7, 12.3) 32 (24, 35) 1,428 68.3
New Jersey 3 *** 13.1 (12.8, 13.5) 12 (7, 24) 1,391 59.8
Georgia 3 *** 12.0 (11.7, 12.3) 31 (23, 35) 1,300 66.3
Wisconsin 6 *** 15.1 (14.7, 15.5) 1 (1, 4) 1,065 71.5
Virginia 6 *** 11.0 (10.7, 11.3) 38 (35, 42) 1,055 65.7
Washington 5 *** 12.1 (11.7, 12.4) 30 (22, 35) 1,000 62.4
Indiana 6 *** 12.8 (12.4, 13.1) 22 (10, 29) 976 69.2
Missouri 6 *** 12.8 (12.5, 13.2) 21 (8, 28) 952 69.5
Minnesota 6 *** 14.3 (13.9, 14.7) 4 (2, 8) 923 67.0
Tennessee 6 *** 11.0 (10.7, 11.4) 37 (34, 42) 876 62.2
Maryland 6 *** 12.5 (12.1, 12.9) 25 (13, 32) 865 70.3
Arizona 6 *** 9.1 (8.9, 9.4) 48 (44, 49) 762 59.4
Kentucky 3 *** 13.5 (13.0, 14.0) 8 (4, 20) 712 68.6
Colorado 6 *** 12.0 (11.6, 12.4) 33 (23, 35) 700 70.3
Louisiana 3 *** 12.3 (11.9, 12.8) 27 (15, 34) 646 65.4
South Carolina 6 *** 10.6 (10.2, 11.0) 41 (36, 43) 640 63.6
Oregon 6 *** 12.4 (11.9, 12.8) 26 (14, 34) 619 66.1
Connecticut 3 *** 13.0 (12.5, 13.5) 16 (6, 28) 585 62.7
Alabama 6 *** 9.7 (9.4, 10.1) 44 (42, 48) 570 61.5
Iowa 3 *** 14.7 (14.1, 15.2) 2 (1, 7) 555 69.1
Oklahoma 6 *** 11.4 (11.0, 11.9) 35 (29, 41) 510 64.3
Kansas 6 *** 12.7 (12.2, 13.3) 23 (8, 33) 426 66.2
Arkansas 6 *** 10.9 (10.5, 11.5) 39 (34, 43) 397 60.8
Mississippi 6 *** 10.9 (10.4, 11.4) 40 (34, 43) 369 64.2
Utah 3 *** 12.6 (12.0, 13.2) 24 (8, 34) 331 68.9
West Virginia 6 *** 13.5 (12.9, 14.2) 7 (3, 25) 331 69.6
Nebraska 6 *** 13.3 (12.6, 14.0) 10 (3, 27) 292 66.3
Maine 6 *** 14.6 (13.8, 15.4) 3 (1, 10) 274 70.6
Idaho 3 *** 13.2 (12.4, 13.9) 11 (4, 31) 249 67.6
Nevada 6 *** 9.1 (8.6, 9.7) 49 (43, 50) 238 59.4
Puerto Rico 6 *** 5.2 (4.9, 5.5) N/A 228 36.0
New Hampshire 6 *** 13.0 (12.2, 13.8) 17 (4, 34) 225 63.2
New Mexico 3 *** 8.2 (7.6, 8.7) 50 (48, 50) 206 54.5
Hawaii 3 *** 9.4 (8.8, 10.1) 45 (42, 49) 167 59.0
Montana 6 *** 12.2 (11.3, 13.1) 29 (8, 40) 164 66.6
Delaware 6 *** 13.4 (12.5, 14.4) 9 (1, 31) 163 69.3
Rhode Island 6 *** 12.2 (11.4, 13.2) 28 (7, 39) 160 62.8
South Dakota 6 *** 13.7 (12.6, 14.8) 6 (1, 32) 139 69.9
North Dakota 6 *** 12.9 (11.8, 14.1) 19 (3, 36) 109 69.4
Vermont 6 *** 12.9 (11.8, 14.1) 20 (3, 36) 107 67.7
Alaska 6 *** 10.3 (9.2, 11.5) 42 (30, 49) 73 62.0
Wyoming 6 *** 9.4 (8.3, 10.5) 47 (38, 50) 63 56.2
District of Columbia 6 *** 9.4 (8.3, 10.5) 46 (38, 50) 62 63.3
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/26/2021 4:37 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top